These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10759364)

  • 21. The Use of Intranasal Midazolam in a Special Care Dentistry Department: Technique and Cases.
    Drysdale D
    Prim Dent J; 2015 May; 4(2):42-8. PubMed ID: 26556257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma concentrations and sedation scores after nebulized and intranasal midazolam in healthy volunteers.
    McCormick AS; Thomas VL; Berry D; Thomas PW
    Br J Anaesth; 2008 May; 100(5):631-6. PubMed ID: 18385262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of Midazolam as an Intranasal Sedative in Dentistry.
    Greaves A
    SAAD Dig; 2016 Jan; 32():46-9. PubMed ID: 27145560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atomised intranasal midazolam spray as premedication in pediatric patients: comparison between two doses of 0.2 and 0.3 mg/kg.
    Baldwa NM; Padvi AV; Dave NM; Garasia MB
    J Anesth; 2012 Jun; 26(3):346-50. PubMed ID: 22395260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intranasal dexmedetomidine vs midazolam for premedication in children undergoing complete dental rehabilitation: a double-blinded randomized controlled trial.
    Sheta SA; Al-Sarheed MA; Abdelhalim AA
    Paediatr Anaesth; 2014 Feb; 24(2):181-9. PubMed ID: 24237879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety, Pharmacokinetics, and Pharmacodynamics of Midazolam Gel After Rectal Administration in Healthy Chinese Subjects.
    Zhou S; Zhu J; Sun X; Xie L; Zhao Y; Ding S; Wang L; Chen J; Zhu B; Zheng A; Li Y; Zhou C; Shao F
    Clin Drug Investig; 2023 Jun; 43(6):421-433. PubMed ID: 37270744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of midazolam in children: comparative study of intranasal and intravenous administration.
    Rey E; Delaunay L; Pons G; Murat I; Richard MO; Saint-Maurice C; Olive G
    Eur J Clin Pharmacol; 1991; 41(4):355-7. PubMed ID: 1804652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam.
    Albrecht S; Ihmsen H; Hering W; Geisslinger G; Dingemanse J; Schwilden H; Schüttler J
    Clin Pharmacol Ther; 1999 Jun; 65(6):630-9. PubMed ID: 10391668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.
    Antonik LJ; Goldwater DR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):274-83. PubMed ID: 22190555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and pharmacodynamics of a new intranasal midazolam formulation in healthy volunteers.
    Wermeling DP; Record KA; Kelly TH; Archer SM; Clinch T; Rudy AC
    Anesth Analg; 2006 Aug; 103(2):344-9, table of contents. PubMed ID: 16861415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The pharmacokinetics of midazolam following intramuscular administration].
    Behne M; Janshon G; Asskali F; Förster H
    Anaesthesist; 1989 Jun; 38(6):278-84. PubMed ID: 2764268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of saquinavir on the pharmacokinetics and pharmacodynamics of oral and intravenous midazolam.
    Palkama VJ; Ahonen J; Neuvonen PJ; Olkkola KT
    Clin Pharmacol Ther; 1999 Jul; 66(1):33-9. PubMed ID: 10430107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does intranasal dexmedetomidine provide adequate plasma concentrations for sedation in children: a pharmacokinetic study.
    Miller JW; Balyan R; Dong M; Mahmoud M; Lam JE; Pratap JN; Paquin JR; Li BL; Spaeth JP; Vinks A; Loepke AW
    Br J Anaesth; 2018 May; 120(5):1056-1065. PubMed ID: 29661383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Two-way Randomized Cross-over Pharmacokinetic and Pharmacodynamic Study of an Innovative Oral Solution of Midazolam (ADV6209).
    Guittet C; Manso M; Burton I; Granier LA; Marçon F
    Pharm Res; 2017 Sep; 34(9):1840-1848. PubMed ID: 28577272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and pharmacodynamics of intranasal remimazolam-a randomized controlled clinical trial.
    Pesic M; Schippers F; Saunders R; Webster L; Donsbach M; Stoehr T
    Eur J Clin Pharmacol; 2020 Nov; 76(11):1505-1516. PubMed ID: 32886178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of intranasal administration of xylazine, diazepam, and midazolam in budgerigars (Melopsittacus undulatus): clinical evaluation.
    Sadegh AB
    J Zoo Wildl Med; 2013 Jun; 44(2):241-4. PubMed ID: 23805540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative absorption kinetics of intramuscular midazolam and diazepam.
    Hung OR; Dyck JB; Varvel J; Shafer SL; Stanski DR
    Can J Anaesth; 1996 May; 43(5 Pt 1):450-5. PubMed ID: 8723850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of midazolam given as an intranasal spray to adult surgical patients.
    Björkman S; Rigemar G; Idvall J
    Br J Anaesth; 1997 Nov; 79(5):575-80. PubMed ID: 9422893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Randomized Controlled Trial Comparing Intranasal Midazolam and Chloral Hydrate for Procedural Sedation in Children.
    Stephen MC; Mathew J; Varghese AM; Kurien M; Mathew GA
    Otolaryngol Head Neck Surg; 2015 Dec; 153(6):1042-50. PubMed ID: 26286872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients.
    de Wildt SN; de Hoog M; Vinks AA; van der Giesen E; van den Anker JN
    Crit Care Med; 2003 Jul; 31(7):1952-8. PubMed ID: 12847388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.